What Happens When a Patent Is Challenged? Free eBook

For organisations operating in pharmaceuticals, biotechnology, medical technology and agricultural sciences, intellectual property is often among their most valuable assets.

Years of research. Significant investment. Regulatory hurdles. Clinical or field trials. Product development. Commercialisation.

Much of this investment ultimately relies on the strength and enforceability of patent rights.

But what happens when those rights are challenged?

Would you know what options are available if a competitor launched a potentially infringing product?

Would you know how quickly Australian patent proceedings can move, or what steps can be taken to protect market position while a dispute is ongoing?

Could your business respond effectively if a patent covering a critical product, platform technology, biologic, diagnostic tool or agricultural innovation came under attack?

These are questions many organisations do not consider until a dispute has already emerged.

By then, the commercial stakes can be significant.

A patent dispute can affect product launches, market exclusivity, licensing opportunities, investment decisions and long-term commercial strategy.

For pharmaceutical companies, the consequences may extend even further. The outcome of litigation can influence pricing, reimbursement pathways and the timing of generic or biosimilar market entry.

For biotechnology, medical technology and agricultural businesses, a dispute may impact access to key technologies, breeding innovations, manufacturing processes, diagnostics, formulations or research partnerships.

Understanding the litigation landscape before a dispute arises is therefore not simply a legal exercise.

It is an important component of risk management and strategic planning.

Some questions businesses should consider include:

• What happens when a patent infringement claim is filed in Australia?
• How can competitors challenge the validity of a patent?
• When might urgent court intervention be available?
• What role do expert witnesses play in complex scientific disputes?
• How does discovery work when technical information and confidential research are involved?
• How long do patent proceedings typically take?
• What strategic considerations can influence the outcome before a matter even reaches trial?
• What unique issues arise in pharmaceutical and life sciences patent disputes?

The answers to these questions are rarely straightforward.

To help innovators, patent owners and life sciences businesses better understand the Australian patent litigation landscape, we have prepared our free e-book, Patent Litigation in Australia, which provides an overview of the key stages, procedures and strategic considerations involved in patent disputes, with a particular focus on pharmaceutical and life sciences matters.

Download the guide and gain a clearer understanding of what may be involved when innovation is put to the test.

Pearce IP can assist in Australia, New Zealand and internationally. Use our Contact Form or email us at info@pearceIP.law or call Australia Tel: +61 (0) 2 9023 9988 or New Zealand Tel: +64 (4) 886 1199.

About Pearce IP

Pearce IP is a privately owned/independent, specialist, life-sciences focussed, intellectual property/law firm offering lawyers and attorneys in Australia and New Zealand.

Our lawyers and attorneys specialise in pharma, biopharma, biotech, ag-tech, food-tech, med-tech, although our work is broader than these industries.

Pearce IP and its leaders are ranked in every notable legal directory including: Chambers & Partners, Legal 500, IAM Patent 1000, IAM Strategy 300, MIP IP Stars, Doyles Guide, WTR 1000, Best Lawyers, WIPR Leaders, Best Law Firms, among others. In 2025, Pearce IP was honoured by Australasian Lawyer and New Zealand Lawyer as a Top Specialist Firm, 5 Star Employer of Choice, and the “Standout Winner” for Inclusion and Culture (<100 employees).  

Pearce IP is the only leading IP firm in Australia and New Zealand with a female founder, and is certified by WEConnect International as women owned.